Clinical Trial Update: ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC) [Phase 1]

View source ↗

Summary

Phase 1 dengue virus live-virus human challenge study (DENV-1-LVHC) using ADVP005 completed with results posted on 2025-02-27.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• ADVP005
• DENV-1-LVHC

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Dengue | Phase 1 | Status: COMPLETED | Results posted: 2025-02-27